SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001558370-19-000323
Filing Date
2019-01-31
Accepted
2019-01-31 17:29:42
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 s-3.htm S-3 682521
2 EX-5.1 ex-5d1.htm EX-5.1 38900
3 EX-23.1 ex-23d1.htm EX-23.1 6277
4 GRAPHIC ex-5d1g001.jpg GRAPHIC 11318
5 GRAPHIC s-3g001.jpg GRAPHIC 18452
6 GRAPHIC s-3g002.jpg GRAPHIC 23057
  Complete submission text file 0001558370-19-000323.txt   801894
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: S-3 | Act: 33 | File No.: 333-229459 | Film No.: 19556848
SIC: 2834 Pharmaceutical Preparations